[SOME ASPECTS OF THE PHARMACOLOGICAL EFFECTS OF THE BUTYLHYOSCINE-NORAMIDOPYRINE COMBINATION].
D000109:Acetylcholine; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000818:Animals; D058633:Antipyretics; D001001:Anura; D001285:Atropine; D004177:Dipyrone / Q000031:analogs & derivatives; D004386:Duodenum; D006168:Guinea Pigs; D006321:Heart; D007082:Ileum; D007422:Intestines; D007865:Leeches; D051379:Mice; D009119:Muscle Contraction; D009125:Muscle Relaxants, Central; D009130:Muscle, Smooth; D009132:Muscles; D009206:Myocardium; D010600:Pharmacology; D011343:Procaine; D051381:Rats; D012106:Research; D012908:Snails; D013644:Tartrates
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D009125:Muscle Relaxants, Central; D013644:Tartrates; D011343:Procaine; D004177:Dipyrone; D001285:Atropine; D000109:Acetylcholine; C008667:noramidopyrine
ACETYLCHOLINE; ANALGESICS AND ANTIPYRETICS; ATROPINE; DUODENUM; EXPERIMENTAL LAB STUDY; FROGS; GUINEA PIGS; HEART; ILEUM; INTESTINES; LEECHES; MICE; MUSCLE CONTRACTION; MUSCLE RELAXANTS; MUSCLE, SMOOTH; MUSCLES; MYOCARDIUM; PHARMACOLOGY; PROCAINE; RATS; SNAILS; TARTRATES
QUELQUES ASPECTS DES EFFETS PHARMACOLOGIQUES DE L'ASSOCIATION BUTYL-HYOSCINE-NORAMIDOPYRINE.